Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dino Di Carlo
AddedMar 31, 2024
UpdatedMay 31, 2026
Dino Di Carlo

Dino Di Carlo

Board Member, Tempo Therapeutics

CrunchbaseLinkedIn

Dino Di Carlo's Career

Tempo Therapeutics
Tempo Therapeutics

San Diego, CA, US

Board Member· Board
Forcyte Biotechnologies
Forcyte Biotechnologies

Los Angeles, CA, US

Board Member· Board
Partillion Bioscience
Partillion Bioscience

Los Angeles, CA, US

Board Member· Board
Cytovale
Cytovale

San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dino Di Carlo's Career

Tempo Therapeutics
Tempo Therapeutics
$4.1M162014San Diego, CA, US
Board Member· Board

Leadership at Tempo Therapeutics

Westbrook WeaverWestbrook WeaverFounder

Similar to Tempo Therapeutics

Tune TherapeuticsTune TherapeuticsSeattle, WA, USGene Therapy, Therapeuticsest. 2020Tune TherapeuticsSeattle, WA, US · est. 2020

Tune Therapeutics: Pioneering regenerative medicine through fine-tuning gene networks with our TEMPO platform.

$40M104
TheraJectTheraJectFremont, CA, USDrug Delivery, Vaccinesest. 2002TheraJectFremont, CA, US · est. 2002

TheraJect, Inc.: A preclinical biopharmaceutical firm innovating needle-free vaccine delivery.

$500k5
Attivare TherapeuticsAttivare TherapeuticsNatick, MA, USBiomaterials, Vaccinesest. 2020Attivare TherapeuticsNatick, MA, US · est. 2020

Innovative biomaterial vaccine developer for diverse applications.

$6M7
Mapp BiopharmaceuticalMapp BiopharmaceuticalSan Diego, CA, USPharmaceuticalsest. 2003Mapp BiopharmaceuticalSan Diego, CA, US · est. 2003

Mapp Biopharmaceutical: Innovating infectious disease prevention with ZMapp Ebola vaccine.

$16.5M68
Forcyte Biotechnologies
Forcyte Biotechnologies
Series Unknown$125k72017Los Angeles, CA, US
Board Member· Board

Leadership at Forcyte Biotechnologies

Robert DamoiseauxRobert DamoiseauxCo-Founder
Dino Di CarloDino Di CarloFounder
Ivan PushkarskyIvan PushkarskyCo-Founder
Ivan PushkarskyIvan PushkarskyFounder
Partillion Bioscience
Partillion Bioscience
$6.1M52020Los Angeles, CA, US
Board Member· Board

Similar to Partillion Bioscience

Parse BiosciencesParse BiosciencesSeattle, WA, USData Analysis, Sequencingest. 2018Parse BiosciencesSeattle, WA, US · est. 2018

Seattle-based Parse Biosciences offers scalable single-cell sequencing platforms to accelerate scientific research.

$100M119
CelldomCelldomDurham, NC, USSingle-Cell Analysisest. 2016CelldomDurham, NC, US · est. 2016

Celldom advances research and drug development with high-throughput, next-gen single-cell analysis technology.

$1.9M5
DeepcellDeepcellMenlo Park, CA, USSoftwareest. 2017DeepcellMenlo Park, CA, US · est. 2017

Deepcell: Pioneering single-cell analysis software for enhanced disease diagnosis and treatment.

$98M111
Scribe BiosciencesScribe BiosciencesSan Francisco, CA, USBiotechest. 2017Scribe BiosciencesSan Francisco, CA, US · est. 2017

Scribe Biosciences: Pioneering tech for immunotherapy discoveries via single-cell profiling.

$3.1M7
Cytovale
Cytovale
$128.6M912013San Francisco, CA, US
Board Member· Board

Leadership at Cytovale

Ajay ShahAjay ShahCEO
Henry TseHenry TseCo-Founder
Lindy FishburneLindy FishburneBoard Member
Jack FuchsJack FuchsBoard Member

People Similar to Dino Di Carlo

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMani SrivastavaMani SrivastavaBoard Member · UclaJosh HymanJosh HymanBoard Member · UclaAshley SandersAshley SandersBoard Member · UclaEddie Wang RodriguezEddie Wang RodriguezCo-Founder · Teal VenturesGary LauerGary LauerBoard Member · University of Southern CaliforniaGregory ProbertGregory ProbertBoard Member · University of Southern California